ATRICURE INC (ATRC) Stock Price & Overview

NASDAQ:ATRC • US04963C2098

29.39 USD
-0.63 (-2.1%)
At close: Mar 9, 2026
29.39 USD
0 (0%)
After Hours: 3/9/2026, 6:40:06 PM

The current stock price of ATRC is 29.39 USD. Today ATRC is down by -2.1%. In the past month the price decreased by -20.8%. In the past year, price decreased by -11.77%.

ATRC Key Statistics

52-Week Range28.29 - 43.18
Current ATRC stock price positioned within its 52-week range.
1-Month Range28.41 - 38.07
Current ATRC stock price positioned within its 1-month range.
Market Cap
1.464B
P/E
N/A
Fwd P/E
461.02
EPS (TTM)
-0.13
Dividend Yield
N/A

ATRC Stock Performance

Today
-2.1%
1 Week
-4.98%
1 Month
-20.80%
3 Months
-30.65%
Longer-term
6 Months -16.20%
1 Year -11.77%
2 Years -3.39%
3 Years -29.10%
5 Years -55.14%
10 Years +74.63%

ATRC Stock Chart

ATRICURE INC / ATRC Daily stock chart

ATRC Technical Analysis

ChartMill assigns a technical rating of 0 / 10 to ATRC. When comparing the yearly performance of all stocks, ATRC is a bad performer in the overall market: 85.42% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating
ATRC Full Technical Analysis Report

ATRC Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to ATRC. While ATRC has a great health rating, there are worries on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
ATRC Full Fundamental Analysis Report

ATRC Earnings

On February 17, 2026 ATRC reported an EPS of 0.04 and a revenue of 140.50M. The company beat EPS expectations (141.28% surprise) and missed revenue expectations (-1.45% surprise).

Next Earnings DateApr 27, 2026
Last Earnings DateFeb 17, 2026
PeriodQ4 / 2025
EPS Reported$0.04
Revenue Reported140.5M
EPS Surprise 141.28%
Revenue Surprise -1.45%
ATRC Earnings History

ATRC Forecast & Estimates

15 analysts have analysed ATRC and the average price target is 52.31 USD. This implies a price increase of 77.99% is expected in the next year compared to the current price of 29.39.

For the next year, analysts expect an EPS growth of 149.04% and a revenue growth 13.05% for ATRC


Analysts
Analysts81.33
Price Target52.31 (77.99%)
EPS Next Y149.04%
Revenue Next Year13.05%
ATRC Forecast & Estimates

ATRC Groups

Sector & Classification

ATRC Financial Highlights

Over the last trailing twelve months ATRC reported a non-GAAP Earnings per Share(EPS) of -0.13. The EPS increased by 81.43% compared to the year before.


Income Statements
Revenue(TTM)534.53M
Net Income(TTM)-11.45M
Industry RankSector Rank
PM (TTM) N/A
ROA -1.75%
ROE -2.33%
Debt/Equity 0.14
Chartmill High Growth Momentum
EPS Q2Q%150%
Sales Q2Q%13.05%
EPS 1Y (TTM)81.43%
Revenue 1Y (TTM)14.88%
ATRC financials

ATRC Ownership

Ownership
Inst Owners100.89%
Shares49.81M
Float47.96M
Ins Owners3.37%
Short Float %7.18%
Short Ratio5.48
ATRC Ownership

ATRC Latest News, Press Relases and Analysis

All ATRC news

ATRC Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
ABT ABBOTT LABORATORIES19.61190.38B
ISRG INTUITIVE SURGICAL INC48.29174.071B
SYK STRYKER CORP24.19139.513B
BSX BOSTON SCIENTIFIC CORP20.56105.876B
IDXX IDEXX LABORATORIES INC41.1848.442B
BDX BECTON DICKINSON AND CO12.1447.586B
EW EDWARDS LIFESCIENCES CORP28.3447.376B
RMD RESMED INC20.636.838B
GEHC GE HEALTHCARE TECHNOLOGY14.6333.849B
DXCM DEXCOM INC27.0426.209B
ZBH ZIMMER BIOMET HOLDINGS INC1118.413B
HOLX HOLOGIC INC15.416.908B
PODD INSULET CORP37.1816.686B

About ATRC

Company Profile

ATRC logo image AtriCure, Inc. engages in the development, manufacture, and sale of surgical ablation of cardiac tissue, and systems for the exclusion of the left atrial appendage. The company is headquartered in Mason, Ohio and currently employs 1,350 full-time employees. The company went IPO on 2005-08-05. The firm's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The firm's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.

Company Info

ATRICURE INC

7555 Innovation Way

Mason OHIO 45040 US

CEO: Michael H. Carrel

Employees: 1300

ATRC Company Website

ATRC Investor Relations

Phone: 15137554100

ATRICURE INC / ATRC FAQ

What does ATRC do?

AtriCure, Inc. engages in the development, manufacture, and sale of surgical ablation of cardiac tissue, and systems for the exclusion of the left atrial appendage. The company is headquartered in Mason, Ohio and currently employs 1,350 full-time employees. The company went IPO on 2005-08-05. The firm's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The firm's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.


What is the current price of ATRC stock?

The current stock price of ATRC is 29.39 USD. The price decreased by -2.1% in the last trading session.


Does ATRC stock pay dividends?

ATRC does not pay a dividend.


How is the ChartMill rating for ATRICURE INC?

ATRC has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


What sector and industry does ATRICURE INC belong to?

ATRICURE INC (ATRC) operates in the Health Care sector and the Health Care Equipment & Supplies industry.


What is the employee count for ATRC stock?

ATRICURE INC (ATRC) currently has 1300 employees.


Who owns ATRICURE INC?

You can find the ownership structure of ATRICURE INC (ATRC) on the Ownership tab.